Sirius Genomics Receives NRC-IRAP Funding for Development of New Biomarkers

VANCOUVER, October 5, 2010 – Sirius Genomics, a developer of companion diagnostics, announced today
that it has signed its second Contribution Agreement with the National
Research Council of Canada Industrial Research Assistance Program (NRC-IRAP).

This research funding will be applied to discovery of genomic biomarkers
that are predictive of patient response to therapeutics used [...]

Blood Pressure Pills More Effective When Taken at Night

New Research Which Shows That Timing Blood Pressure Medication With a Patient's Body Clock Make it More Effective and Offers Greater Protection Against the Occurrence of Heart Attacks and Strokes is Set to Change the Hypertension Treatment for Hundreds of Millions of People Worldwide

NEW YORK, October 5, 2010 – Chronobiology International – the international [...]

World-Check Launches Best Practice Iran Sanctions Solution – Two New Products to Help Clients Identify Iran Regulatory and Reputational Risk

Market Leader Dedicates its Unparalleled Resources to Help its 4,500+ Clients Meet Their New Requirements

LONDON, October 5, 2010 – World-Check today announced the launch of its Iran Economic Interest
(IEI) solution following a raft of new international legislation including
the U.S. Government's Comprehensive Iran Sanctions, Accountability and
Divestment Act (CISADA) of July 2010, U.N. Security Council Resolution [...]

Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer’s Disease

BROOMFIELD, Colorado, October 5, 2010 – Accera, Inc., a medical research and development company delivering
breakthrough therapies for serious diseases such as Alzheimer's disease (AD),
announced today that Thomas Werner, Ph.D., has been appointed President and
CEO. Concurrently with Dr. Werner's appointment, the U.S. Food and Drug
Administration (FDA) has accepted Accera's Investigational New Drug (IND)
application to conduct [...]

Nobel Prize for Scientist Professor Robert G. Edwards, Editor Emeritus of Reproductive BioMedicine Online

CAMBRIDGE, England, October 5, 2010 – Elsevier congratulates Cambridge scientist and Editor Emeritus of
Reproductive BioMedicine Online (RBMOnline), Robert G. Edwards, who has been
awarded with the 2010 Nobel Prize in Medicine for the development of in-vitro
fertilisation (IVF), a breakthrough that has helped millions of infertile
couples worldwide to have children. Professor Edwards, 85, started working on
IVF, [...]

Amsterdam Molecular Therapeutics Launches Equity Offering of up to EUR 15 Million

Not for release, publication or distribution in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Japan or South Africa or to US persons. This announcement is not a prospectus and is not an offer for sale of securities in the United States, Canada, South Africa, Australia, Japan or [...]

Ground Zero Pharmaceuticals Announces Expansion of Global Consulting in Somatic Cell Therapies

IRVINE, California, October 5, 2010 – GZP is pleased to announce that it has expanded its capabilities for
strategic regulatory and product development support of gene therapy and
somatic cell therapies, including treatment vaccines for cancer and other
serious or life-threatening diseases. New senior associates with expertise in
manufacturing and clinical development in these expanding areas allow GZP [...]